Who is this relevant for?

  • Pharmaceutical buyers sourcing medical devices
  • Hospitals managing supply risk
  • Distributors monitoring sourcing opportunities
  • Manufacturers evaluating US market entry

Public list prices for standard polymeric double-J stents in the United States range from $198 to $245 per unit, based on catalog prices from Cook Medical, Boston Scientific, and BD. These visible anchors, however, are not the prices institutional buyers pay.

Modeled commercial corridors derived from GPO contract benchmarks and CMS payment data tell a different story. Standard polymeric ureteral stents clear at 120–180 USD/unit under contract. Drug-eluting stents command 250–400 USD/unit, while metal stents such as Allium or Memokath run 800–1500 USD/unit. The gap between list and realized price comes down to contract discount tiers, pack-size effects, and buyer mix.

For a representative standard stent, the modeled landed price is about 186 USD/unit. Raw materials account for 15–25% of that cost; manufacturing adds 20–30%; regulatory compliance adds 5–10%; distribution and logistics add 10–15%; sales and marketing 15–25%; and OEM profit margin 15–25%.

Buyer segments show distinct premium tolerances. Hospital procurement via GPOs like Vizient or Premier has moderate tolerance and focuses on total cost of care. ASC administrators have high premium sensitivity and prefer lower-cost standard products. Large urology group practices balance volume with willingness to pay for proven outcomes in complex cases.

Key risk factors include the shift to ASCs putting downward pressure on average selling prices, rising urolithiasis prevalence boosting volume but not pricing due to GPO consolidation, and potential biodegradable stent innovation that could command a 30–50% premium. Medicare reimbursement changes and raw material cost inflation add further uncertainty.

This analysis uses publicly available list prices as observed anchors and models commercial corridors from CMS data, GPO contract summaries, and published procurement benchmarks. The resulting price bands are directional, not transactional quotes.